FIELD: medicine.
SUBSTANCE: invention relates to the field of biotechnology, namely to recombinant vaccines against Candida albicans, and can be used in medicine. A vaccine for the treatment or prevention of the Candida infection contains an isolated polypeptide with SEQ ID NO: 2 in an effective quantity, which can be fused with a fusion partner. The vaccine can also contain an adjuvant.
EFFECT: invention makes it possible to increase the effectiveness of treatment or prevention of the Candida infection.
11 cl, 6 dwg, 1 tbl, 2 ex
Authors
Dates
2015-08-10—Published
2010-07-02—Filed